Cargando…
Neutrophil-to-lymphocyte ratio as a prognostic biomarker in hepatocellular carcinoma after transarterial chemoembolization
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576090/ https://www.ncbi.nlm.nih.gov/pubmed/33240973 http://dx.doi.org/10.21037/atm-20-4296 |
| _version_ | 1783597945052987392 |
|---|---|
| author | Jeong, Soung Won |
| author_facet | Jeong, Soung Won |
| author_sort | Jeong, Soung Won |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7576090 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75760902020-11-24 Neutrophil-to-lymphocyte ratio as a prognostic biomarker in hepatocellular carcinoma after transarterial chemoembolization Jeong, Soung Won Ann Transl Med Editorial AME Publishing Company 2020-09 /pmc/articles/PMC7576090/ /pubmed/33240973 http://dx.doi.org/10.21037/atm-20-4296 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Jeong, Soung Won Neutrophil-to-lymphocyte ratio as a prognostic biomarker in hepatocellular carcinoma after transarterial chemoembolization |
| title | Neutrophil-to-lymphocyte ratio as a prognostic biomarker in hepatocellular carcinoma after transarterial chemoembolization |
| title_full | Neutrophil-to-lymphocyte ratio as a prognostic biomarker in hepatocellular carcinoma after transarterial chemoembolization |
| title_fullStr | Neutrophil-to-lymphocyte ratio as a prognostic biomarker in hepatocellular carcinoma after transarterial chemoembolization |
| title_full_unstemmed | Neutrophil-to-lymphocyte ratio as a prognostic biomarker in hepatocellular carcinoma after transarterial chemoembolization |
| title_short | Neutrophil-to-lymphocyte ratio as a prognostic biomarker in hepatocellular carcinoma after transarterial chemoembolization |
| title_sort | neutrophil-to-lymphocyte ratio as a prognostic biomarker in hepatocellular carcinoma after transarterial chemoembolization |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576090/ https://www.ncbi.nlm.nih.gov/pubmed/33240973 http://dx.doi.org/10.21037/atm-20-4296 |
| work_keys_str_mv | AT jeongsoungwon neutrophiltolymphocyteratioasaprognosticbiomarkerinhepatocellularcarcinomaaftertransarterialchemoembolization |